# The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

> **NCT02096380** · — · UNKNOWN · sponsor: **First People's Hospital of Foshan** · enrollment: 120 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** One cycle TPF induction chemotherapy for NPC
- **DRUG:** Three cycles TPF induction chemotherapy for NPC

## Key facts

- **NCT ID:** NCT02096380
- **Lead sponsor:** First People's Hospital of Foshan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2017-12
- **Final completion:** 2018-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2014-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02096380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02096380, "The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02096380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*